Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > J. Ali Satvat > Profile

J. Ali Satvat

Affiliations

at Coherus Oncology Inc. (CHRS), 2025-06-13
at Bridgebio Pharma Inc. (BBIO), 2024-12-31
Director at Impel Neuropharma Inc (IMPL), 2021-04-22
Director at Eidos Therapeutics Inc. (EIDX), 2021-01-29

Insider Trading: Purchases See All

Symbol	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
EIDX	$29.90	882,353	$26,382,795.88	24,575,501	2019-07-03	Filing
EIDX	$25.93	1,103,848	$28,622,778.64	23,693,148	2019-05-24	Filing
EIDX	$13.96	2,664	$37,189.44	22,589,300	2018-12-10	Filing
EIDX	$13.29	37,989	$504,873.81	22,586,636	2018-12-10	Filing
EIDX	$14.36	4,860	$69,789.60	22,548,647	2018-12-07	Filing